Our findings provide evidence that reactivation of EBV infection in MS patients might program the early differentiation of MBCs towards a pathway that supports T cell activation, likely in an episodic manner, and that this is mainly observed in IgM+ MBCs. The gene discussed is CD40LG; the disease is myeloid sarcoma.